Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study

Annals of Internal Medicine

Volumn 132, Issue 4, 2000, Pages 270-278

  Hak, A Elisabeth ^a   Pols, Huibert A P ^a   Visser, Theo J ^a   Drexhage, Hemmo A ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034651789     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-4-200002150-00004     Document Type: Article

References (52)

1. Vanhaelst L, Neve P, Chailly P, Bastenie PA. Coronary-artery disease in nypothyroidism. Observations in clinical myxoedema. Lancet. 1967;2:800-2.
2. Steinberg AD. Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med. 1968;68:338-44.
3. Klein I, Ojamaa K. The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid. 7th ed. Philadelphia: Lippincott-Raven; 1996:799-804.
4. Helfand M, Redfern CC. Clinical guideline, part 2. Screening for thyroid disease: an update American College of Physicians. Ann Intern Med. 1998; 129:144-58.
5. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol (Oxf). 1977;7:481-93.
6. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985;145:1386-8.
7. Heinonen OP, Gordin A, Aho K, Punsar S, Pyorala K, Puro K. Symptomless autoimmune thyroiditis in coronary heart-disease. Lancet. 1972; 1: 785-6.
8. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrmol (Oxf). 1977;7:495-508.
9. Tièche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H, Burgi H. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J. 1981;46:202-6.
10. Dean JW, Fowler PB. Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. Br Med J (Clin Res Ed). 1985;290:1555-61.
11. Miura S, litaka M, Suzuki S, Fukasawa N, Kitahama S, Kawakami Y, et al. Decrease in serum levels of thyroid hormone in patients with coronary heart disease. Endocr J. 1996;43:657-63.
12. Bastenie PA, Vanhaelst L, Neve P. Coronary-artery disease in hypothyroidism. Lancet. 1967;2:1221-2.
13. Gaspar IA. Postmortem observations on the thyroid in atherosclerosis. J Am Geriatr Soc. 1968;16:686-95.
14. Bastenie PA, Vanhaelst L, Bonnyns M, Neve P, Staquet M. Preclinical hypothyoidism: a risk factor for coronary heart-disease. Lancet. 1971;1:203-4.
15. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The development of iscnemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6:155-60.
16. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7:403-22.
17. van Gent CM, van der Voort HA, de Bruyn AM, Klein F. Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures. Clin Chim Acta. 1977;75:243-51.
18. Trantow T, Herzog R, Gegenheimer L, Lucker PW. A new method for the determination of the bioavailability of thyroid hormone preparations Methods Find Exp Clin Pharmacol. 1994;16:133-40.
19. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Hofman A. Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in women. Circulation. 1993;88(5 Pt 1):2156-62.
20. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504-7.
21. Hyman JB, Epstein FH. A study of the correlation between roentgenographic and post-mortem calcifications of the aorta. Am Heart J. 1954;48: 540-3.
22. Bots ML, Witteman JC, Grobbee DE. Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis. 1993;102:99-105.
23. Witteman JC, Kannel WB, Wolf PA, Grobbee DE, Hofman A, D'Agostino RB, et al. Aortic calcified plagues and cardiovascular disease (the Framingham Study). Am J Cardiol. 1990;66:1060-4.
24. Witteman JC, Kok FJ, van Saase JL, Valkenburg HA. Aortic calcification as a predictor of cardiovascular mortality. Lancet. 1986;2:1120-2.
25. van Bemmel JH, Kors JA, van Herpen G. Methodology of the modular ECG analysis system MEANS Methods Inf Med. 1990;29:346-53.
26. Willems JL, Abreu-Lima C, Arnaud P, van Bemmel JH, Brohet C, Degani R, et al. The diagnostic performance of computer programs for the interpretation of electrocardiograms. N Engl J Med. 1991;325:1767-73.
27. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. v 1. World Health Organization. Geneva: World Health Organization; 1992.
28. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med. 1997;126:63-73.
29. Brass EP. Effects of antihypertensive drugs on endocrine function. Drugs. 1984;27:447-58.
30. Hennekens CH, Buring JE. Epidemiology in Medicine. v 1. Boston: Little, Brown; 1987.
31. Wong ET, Bradley SG, Schultz AL. Elevations of thyroid-stimulating hormone during acute nonthyroidal illness. Arch Intern Med. 1981;141:873-5.
32. Brent GA, Hershman JM, Braunstein GD. Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med. 1986;81:463-6.
33. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34:77-83.
34. Powell J, Zadeh JA, Carter G, Greenhalgh RM, Fowler PB. Raised serum tryrotrophin in women with peripheral arterial disease. Br J Surg. 1987;74: 1139-41.
35. Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E. Hypothyroidism in the elderly. Endocr Rev. 1987;8:142-53.
36. Mathews JD, Whittingham S, Mackay IR. Autoimmune mechanisms in human vascular disease. Lancet. 1974;2:1423-7.
37. Bastenie PA, Vanhaelst L, Golstein J, Smets P. Asymptomatic autoimmune thyroiditis and coronary heart-disease. Cross-sectional and prospective studies. Lancet. 1977;2:155-8.
38. Fowler PB, Swale J, Andrews H. Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet. 1970;2:488-91.
39. Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol. 1988;28:157-63.
40. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf). 1990;33:519-23.
41. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92:631-42.
42. Kung AW, Pang RW, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf). 1995;43:445-9.
43. Nilsson G, Nordlander S, Levin K. Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med Scand. 1976;200: 63-7.
44. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol (Oxf). 1992;37:411-4.
45. Geul KW, van Sluisveld IL, Grobbee DE, Docter R, de Bruyn AM, Hooykaas H, et al. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin Endocrinol (Oxf). 1993;39:275-80.
46. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab. 1997;82:3421-4.
47. Mamiya S, Hagiwara M, Inoue S, Hidaka H. Thyroid hormones inhibit platelet function and myosin light chain kinase. J Biol Chem. 1989;264:8575-9.
48. Masaki H, Nishikawa M, Urakami M, Yoshimura M, Toyoda N, Mori Y, et al. 3,3′,5′-Triiodothyronine inhibits collagen-induced human platelet aggregation. J Clin Endocrinol Metab. 1992;75:721-5.
49. Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H. Thyroid hormones directly interact with vascular smooth muscle strips. Mol Pharmacol. 1989;35:760-5.
50. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma p-dimer levels. Thromb Haemost. 1998;79:99-103.
51. Koltringer P, Eber O, Wakonig P, Klima G, Lind P. Hypothyroidism and the influence on human blood rheology. J Endocrinol Invest. 1988;11:267-72.
52. Nedrebo BG, Ericsson UB, Nygard O, Refsum H, Ueland PM, Aakvaag A, et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism. 1998;47:89-93.